Neuropeptides
Semax
A synthetic heptapeptide derived from an ACTH fragment.
Early human evidence
- Evidence
- Early clinical
- Status
- Published
Topic authority hub
A cross-catalog research methods hub for peptide identity, model selection, extraction depth, and comparison discipline.
The peptide-research hub is the editorial backbone for Atlas. It groups compounds by identity, evidence maturity, verified studies, and comparison context.
It is intentionally methods-heavy: the goal is to help readers distinguish catalog identity, citation verification, mechanism hypotheses, and human evidence.
Neuropeptides
A synthetic heptapeptide derived from an ACTH fragment.
Early human evidence
Neuropeptides
A synthetic tuftsin-related heptapeptide.
Early human evidence
Bioregulatory peptides
A short synthetic tripeptide studied in bioregulation models.
Preclinical foundation
Bioregulatory peptides
A tetrapeptide investigated within short-peptide bioregulation research.
Preclinical foundation
Immune signaling
A thymic peptide with a substantial immune-signaling literature.
Substantial clinical evidence
Repair & matrix
A copper-binding tripeptide complex studied in matrix biology.
Developing clinical evidence
Metabolic signaling
A mitochondrial-derived peptide studied in metabolic signaling.
Early human evidence
Metabolic signaling
A mitochondria-targeted tetrapeptide indexed in the literature as elamipretide and MTP-131.
Developing clinical evidence
Verified PubMed record for Semax: Functional Connectomic Approach to Studying Selank and Semax Effects.
Verified PubMed record for GHK-Cu: Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.
Verified PubMed record for MOTS-C: MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.
Neuroprotection
Semax has a wider publication footprint than many catalog neuropeptides, but the literature still separates mechanistic models from human inference.
Cognition
Selank’s strongest catalog value is as a mapped research cluster, not as a single simplified mechanism claim.
Healthy aging
Pinealon is best understood as a short-peptide bioregulator research cluster with limited independent replication.
Neuroprotection
Cortagen’s research map is narrower than its marketing language often suggests, so the page starts with verified records and stops at their boundary.
Immune function
Thymosin alpha 1 has broader clinical literature than most Atlas peptides, but the evidence remains indication-specific.
Peptide research
GHK-Cu has a deep matrix-biology footprint, but formulation and model boundaries determine what can be claimed.
Mitochondrial health
MOTS-C is an authority bridge between mitochondrial-derived peptides, metabolism, aging, and redox biology.
Mitochondrial health
SS-31 has enough translational literature to deserve its own hub role, but the evidence is still endpoint- and disease-context dependent.